China
Medizinprodukt-Marktintelligenz für China. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Länder-Tabelle zuletzt: 9. Aug. 2026 (kann veraltet sein). 7-Tage-Zahl ist live neu berechnet. Tabellenwert war 341.
Signale der letzten 7 Tage
Pharmosa Biopharm's Inhaled Drug L606 Wins China Approval to Launch Global Phase 3 Trial for Pulmonary Hypertension - finance.biggo.com
Biogen (BIIB) Wins China Approval For At Home Weekly Alzheimer’s Treatment - simplywall.st
China NMPA Accelerates Market Access For Imported Medicines - insights.citeline.com
China approves third medical device standard for brain-computer interfaces - medicalbuyer.co.in
IceCure Secures China NMPA Approval for ProSense Cryoablation System - finance.yahoo.com
IceCure Medical (ICCM) secures China nod for tumor-freezing cancer tool - Stock Titan
China approves a tumor-freezing system from IceCure - Stock Titan
IceCure Medical Receives Regulatory Approval to Market ProSense® in China - PR Newswire